ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IOVA Iovance Biotherapeutics Inc

11.61
-0.19 (-1.61%)
Last Updated: 12:08:05
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,464,539
Bid Price 11.60
Ask Price 11.61
News -
Day High 11.94

Low
3.21

52 Week Range

High
18.33

Day Low 11.585
Share Name Share Symbol Market Stock Type
Iovance Biotherapeutics Inc IOVA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.19 -1.61% 11.61 12:08:05
Open Price Low Price High Price Close Price Previous Close
11.68 11.585 11.94 11.80
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
13,677 1,464,539 US$ 11.76 US$ 17,216,343 - 3.21 - 18.33
Last Trade Type Quantity Price Currency
12:08:46 10 US$ 11.605 USD

Iovance Biotherapeutics (IOVA) Options Flow Summary

Overall Flow

Bearish

Net Premium

-255k

Calls / Puts

125.00%

Buys / Sells

50.00%

OTM / ITM

80.00%

Sweeps Ratio

0.11%

Iovance Biotherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.27B 279.31M - 1.19M -444.04M -1.59 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Iovance Biotherapeutics News

Date Time Source News Article
3/22/202416:30GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under..
3/06/202417:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202407:00Edgar (US Regulatory)Form 8-K - Current report
3/04/202405:30GlobeNewswire Inc.Iovance Biotherapeutics Announces FDA has Lifted Clinical..
3/01/202416:00GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming Conferences
2/29/202406:30Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IOVA Message Board. Create One! See More Posts on IOVA Message Board See More Message Board Posts

Historical IOVA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.6413.2211.5212.194,634,039-1.03-8.15%
1 Month15.0415.9011.5213.564,747,701-3.43-22.81%
3 Months7.7518.337.3413.669,407,4193.8649.81%
6 Months3.6518.333.2110.228,409,3527.96218.08%
1 Year5.8418.333.218.757,156,7025.7798.80%
3 Years29.6033.553.2110.724,445,008-17.99-60.78%
5 Years10.7554.20813.2114.343,302,3590.868.00%

Iovance Biotherapeutics Description

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma.

Your Recent History

Delayed Upgrade Clock